Skip to content

Effects of Temperature Control Liner Materials on Long-Term Outcomes of Prothesis Use

Effects of Temperature Control Liner Materials on Long-Term Outcomes of Prothesis Use

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03428815
Enrollment
42
Registered
2018-02-12
Start date
2019-02-04
Completion date
2020-09-29
Last updated
2021-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Limbs, Skin Diseases

Brief summary

This clinical trial will compare how many days per year people with lower limb prosthesis do not wear their prosthesis when fitted with a conventional liner and a liner made with phase change materials.

Detailed description

Background: The proposed work will generate evidence-based practice guidance for temperature control liner technologies and allow providers to optimize care to Service members and Veterans with limb loss. Sizeable numbers of Service members and Veterans live with limb loss, mostly due to traumatic musculoskeletal injury. Addressing the resulting functional deficit with prostheses increases the risk for secondary conditions such as pressure sores, impaired blood perfusion, and injuries from accidental falls. Any of those occurrences can render the prosthesis temporarily useless, making it challenging for users to engage in many activities of daily life, including work, exercise, and social participation. Many of the described issues originate at the interface between residual limb and prosthetic socket, where the objectives of sufficient weight distribution and suspension are conflicting with the necessity to facilitate heat exchange and limit contact pressure and friction. Recently, prosthesis liners that contain phase-change material have become commercially available, holding the promise that the micro climate at the interface between the residual limb skin and the prosthetic socket can be regulated to reduce the users' tendency to sweat. Preliminary studies on these liners indicate that the socket temperatures inside the socket stayed lower and rose slower than in conventional liners. However, the clinical relevance of those findings remains unclear. While (perceived) socket comfort is certainly an important criterion in prosthesis fitting, it may be claimed that only tangible functional benefits are of concern. Objective/Hypothesis: The purpose of this study is to investigate whether longer (6+ months) periods of use of phase-change material based temperature control liners have clinically meaningful effects. It is hypothesized that use of phase-change material infused liners will improve prosthesis utilization (measured in days of prostheses use per time), physical performance (measured by 2-minute walk test), and self-reported prosthesis related quality of life (assessed by questionnaire). The research follows the rationale that lower and steadier skin temperatures should result in reduced sweat, friction, skin damage, and prosthesis abandonment. This would encourage users to wear their prosthesis for longer periods of time and for an expanded array of purposes, thus increasing their ability to ambulate and to engage in a greater variety of activities. Specific Aims: 1. To compare phase-change material liners to conventional liners with regard to activity and participation 2. To quantify the effect of phase-change material liners on prosthesis related quality of life and physical performance over time 3. To investigate the relationship between perceived benefits of phase-change material liners and patient-centric outcomes Study Design: The proposed study will utilize a double-blind longitudinal cross-over research design. A sample of trans-tibial prosthesis users will be wearing their regular gel or silicone liners for six months and phase-change material liners for another six months in a randomized sequence. Their prostheses will be equipped with activity monitors, and participants will be asked to maintain a record of days when they could not wear their prosthesis due to any perceived issues with their residual limb or socket fit. In 1.5-month intervals, subjects' activity, physical performance, and overall prosthesis assessment will be recorded using standardized methods.

Interventions

DEVICEProsthesis suspension liner

Liners out of phase change material will be fitted

Sponsors

Widener University
CollaboratorOTHER
United States Department of Defense
CollaboratorFED
Goeran Fiedler
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* use of a prosthesis with liner suspension, * at least one year of prosthesis use, * a well-fitting socket, * a matured residual limb (stable limb volume) that has not required socket modifications in the previous year, * the ability to walk with the prosthesis outdoors without notable limitations (K-Level 3), * stable weight, * absence of acute medical conditions that would temporarily affect the ability to use prostheses.

Exclusion criteria

* use of a non-standard liner size, * current use of a PCM liner as the regular suspension system, * known allergies against liner materials, * any inability to understand the protocol and to comply with the associated tasks, such as maintaining a log of days when the prosthesis could not be used. * anticipated provision of a new prosthesis or extended (longer than one month) absences from the region during the study period

Design outcomes

Primary

MeasureTime frameDescription
Days Without Prosthesis6 monthsDays with less than 10% of prosthesis steps than the individual's daily average across the study period. Days without prosthesis are prorated to a full year (365 days) for comparison purposes.

Secondary

MeasureTime frameDescription
Average Daily Step Count6 months per interventionA participant's daily step counts were averaged across days with prosthesis use across each intervention period

Countries

United States

Participant flow

Pre-assignment details

Six participants did not start the protocol: Four had an incompatibility of study liners with their existing socket prosthesis, one had an unrelated health issue, and one was unreachable after enrollment.

Participants by arm

ArmCount
PCM Liner
Willowwood Smart Temp Liner Prosthesis suspension liner: Liners out of phase change material will be fitted
17
Regular Liner
User's regular prescribed liner Prosthesis suspension liner: Liners out of phase change material will be fitted
19
Total36

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyIntermittent fitting issues that affected reliability of data31
Overall StudyLost to Follow-up22
Overall Studysuspension of study activities due to Covid-19 pandemic52

Baseline characteristics

CharacteristicRegular LinerTotalPCM Liner
Age, Continuous59 years
STANDARD_DEVIATION 11
57 years
STANDARD_DEVIATION 12
56 years
STANDARD_DEVIATION 13
Height175 cm
STANDARD_DEVIATION 11
178 cm
STANDARD_DEVIATION 10
181 cm
STANDARD_DEVIATION 7
Mobility score (z-score, PLUS-M)55 units on a scale
STANDARD_DEVIATION 8
56 units on a scale
STANDARD_DEVIATION 7
57 units on a scale
STANDARD_DEVIATION 6
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
19 participants36 participants17 participants
Sex: Female, Male
Female
6 Participants8 Participants2 Participants
Sex: Female, Male
Male
13 Participants28 Participants15 Participants
Weight99 kg
STANDARD_DEVIATION 24
98 kg
STANDARD_DEVIATION 23
97 kg
STANDARD_DEVIATION 23
Years since limb loss10 years
STANDARD_DEVIATION 12
9 years
STANDARD_DEVIATION 10
8 years
STANDARD_DEVIATION 7

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 33
other
Total, other adverse events
1 / 290 / 33
serious
Total, serious adverse events
0 / 290 / 33

Outcome results

Primary

Days Without Prosthesis

Days with less than 10% of prosthesis steps than the individual's daily average across the study period. Days without prosthesis are prorated to a full year (365 days) for comparison purposes.

Time frame: 6 months

Population: only participants with data from both interventions (cross-over design) was included

ArmMeasureValue (MEAN)
PCM LinerDays Without Prosthesis17 prorated days per year
Regular LinerDays Without Prosthesis19 prorated days per year
Secondary

Average Daily Step Count

A participant's daily step counts were averaged across days with prosthesis use across each intervention period

Time frame: 6 months per intervention

ArmMeasureValue (MEAN)Dispersion
PCM LinerAverage Daily Step Count2053 steps per dayStandard Deviation 1249
Regular LinerAverage Daily Step Count2117 steps per dayStandard Deviation 1176

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026